SEMA3A and obesity disorder: Notably, plasma concentrations of SEMA3A have been reported to be elevated in individuals with obesity and type 2 diabetes (T2D)26 as well as in individuals with MASLD27, pointing to a potential relevance of SEMA3A in human obesity and T2D.